These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibitor antibodies to factor VIII and factor IX: management. Lusher JM Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411 [TBL] [Abstract][Full Text] [Related]
5. [A case history of acquired haemophilia A]. Cermáková Z; Hrdličková R; Blahutová S; Ligová A Vnitr Lek; 2013 Apr; 59(4):313-6. PubMed ID: 23711058 [TBL] [Abstract][Full Text] [Related]
6. Acquired haemophilia syndrome: pathophysiology and therapy. Elezović I Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686 [TBL] [Abstract][Full Text] [Related]
7. [Acquired haemophilia due to autoantibodies against factor VIII]. von Depka Prondzinski M Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197 [TBL] [Abstract][Full Text] [Related]
8. Acquired hemophilia a: a current review of autoantibody disease. Sborov DW; Rodgers GM Clin Adv Hematol Oncol; 2012 Jan; 10(1):19-27. PubMed ID: 22398803 [TBL] [Abstract][Full Text] [Related]
9. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057 [TBL] [Abstract][Full Text] [Related]
10. [Acquired hemophilia: current diagnostic and therapeutic approaches]. Lévesque H; Borg JY; Bossi P; Goudemand J; Guillet B; Cabane J Rev Med Interne; 2001 Sep; 22(9):854-66. PubMed ID: 11599187 [TBL] [Abstract][Full Text] [Related]
11. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Shetty S; Bhave M; Ghosh K Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138 [TBL] [Abstract][Full Text] [Related]
12. Management of hemophilia patients with inhibitors. Hedner U; Glazer S Hematol Oncol Clin North Am; 1992 Oct; 6(5):1035-46. PubMed ID: 1400071 [TBL] [Abstract][Full Text] [Related]
13. [Acquired haemophilia A]. Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188 [TBL] [Abstract][Full Text] [Related]
14. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863 [TBL] [Abstract][Full Text] [Related]
16. Current management of acquired factor VIII inhibitors. Barnett B; Kruse-Jarres R; Leissinger CA Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367 [TBL] [Abstract][Full Text] [Related]
17. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor]. Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060 [TBL] [Abstract][Full Text] [Related]
18. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]